BioNTech Sp ADS
BNTX
USD
STOCK MARKET:
NMS
Closed
 
...
Large gap with delayed quotes
Last quote
07/03/2025 - 23:00:00
Bid
07/03/2025 - 18:59:59
Bid
Volume
Ask
07/03/2025 - 18:59:59
Ask
Volume
110.00
+1.74 ( +1.61% )
109.85
300
110.00
1,300
More information
Analysis by TheScreener
01.07.2025
Evaluation Slightly negative  
Interest Weak  
Sensibility High  
Analysis date: 01.07.2025
Global Evaluation
  Slightly negative
The stock is classified in the slightly negative zone since 01.07.2025.
Interest
  Weak
Two stars since 03.06.2025.
Earnings Rev Trend
  Positive
 
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 01.07.2025 at a price of 107.51.
Evaluation
  Strongly overvalued
 
Based on its growth potential and our own criteria, we believe the share price is currently overvalued.
MT Tech Trend
  Positive
 
The forty day technical trend is positive since 03.06.2025.
4wk Rel Perf
  -9.36%
 
The four-week dividend-adjusted underperformance versus SP500 is 9.36%.
Sensibility
  High
The stock has been on the high-sensitivity level since 07.02.2025.
Bear Market Factor
  Low
On average, the stock has a tendency to minimize the drops in the index by -0.03%.
Bad News Factor
  Low
When the stock's pressure is specific, the market sanction on average is 3.72%.
Mkt Cap in $bn
  26.22
With a market capitalization >$8bn, BIONTECH SE is considered a large-cap stock.
G/PE Ratio
  -0.84
A negative ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) indicates that either the forecasted growth is decelerating (negative annualized growth estimate) or the financial analysts are expecting a loss (negative estimated PE).
LT P/E
  -20.78
The estimated PE is negative: the financial analysts' earnings estimates forecast a loss.
LT Growth
  -17.38%
The annualized growth estimate is for the current year to 2027.
Avg. Nb analysts
  19
Over the last seven weeks, an average of 19 analysts provided earnings per share estimates.
Dividend Yield
  0.00%
The company is not paying a dividend.
Beta
  94
For 1% of index variation, the stock varies on average by 0.94%.
Correlation
  0.35
Stock movements are strongly independent of index variations.
Value at Risk
  47.11
The value at risk is estimated at USD 47.11. The risk is therefore 43.82%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
  02.07.2021